These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 1716190)
21. Inhibitory action of metabolites of Pseudomonas aeruginosa against gram-negative bacteria. Li Z; Wang X; Guo Y; Zhao J Kansenshogaku Zasshi; 1995 Aug; 69(8):924-7. PubMed ID: 7594787 [TBL] [Abstract][Full Text] [Related]
22. [Peritonitis determined by the site of intra-abdominal surgery]. Chylak J; Michalska W; Drews M; Marciniak R; Deja A Med Dosw Mikrobiol; 1999; 51(3-4):357-62. PubMed ID: 10803265 [TBL] [Abstract][Full Text] [Related]
23. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria]. Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T Jpn J Antibiot; 2003 Oct; 56(5):458-96. PubMed ID: 14692381 [TBL] [Abstract][Full Text] [Related]
24. [Comparison of frequency and susceptibility to antimicrobials of bacterial strains of the family Enterobacteriaceae isolated from patients hospitalised in intensive care units]. Rudnicka J; Wróblewska M; Marchel H; Luczak M Med Dosw Mikrobiol; 2005; 57(2):185-91. PubMed ID: 16134390 [TBL] [Abstract][Full Text] [Related]
25. An in-vitro study of carbapenem-induced morphological changes and endotoxin release in clinical isolates of gram-negative bacilli. Horii T; Kobayashi M; Sato K; Ichiyama S; Ohta M J Antimicrob Chemother; 1998 Apr; 41(4):435-42. PubMed ID: 9598774 [TBL] [Abstract][Full Text] [Related]
26. A morphological study of the action of equine anti-lipopolysaccharide plasma on gram-negative bacteria. Gaffin SL; Wells MT J Med Microbiol; 1987 Sep; 24(2):165-8. PubMed ID: 3309324 [TBL] [Abstract][Full Text] [Related]
27. [Yearly changes in antibacterial activities of cefozopran against various clinical isolates between 1996 and 2001--II. Gram-negative bacteria]. Suzuki Y; Nishinari C; Endo H; Hiramatsu N; Akiyama K; Koyama T Jpn J Antibiot; 2003 Aug; 56(4):309-35. PubMed ID: 14567255 [TBL] [Abstract][Full Text] [Related]
28. Timely topics in microbiology 1971: gram negative bacteria. Branson D Am J Med Technol; 1973 Nov; 39(11):457-62. PubMed ID: 4201292 [No Abstract] [Full Text] [Related]
29. [Distribution and drug-resistance of 3 500 gram-negative bacteria in Guangzhou]. Xiao QZ; Su DH; Jiang JH; Zhong NS Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):132-8. PubMed ID: 15698988 [TBL] [Abstract][Full Text] [Related]
32. [Frequency and antibiotic resistance of bacteria isolated from urine cultures]. Ceddia T; Gioia G; Mancini A; Marinucci MC Boll Soc Ital Biol Sper; 1979 May; 55(9):894-900. PubMed ID: 121968 [TBL] [Abstract][Full Text] [Related]
33. Susceptibility trends and molecular characterization of Gram-negative bacilli associated with urinary tract and intra-abdominal infections in Jordan and Lebanon: SMART 2011-2013. Hayajneh WA; Hajj A; Hulliel F; Sarkis DK; Irani-Hakimeh N; Kazan L; Badal RE Int J Infect Dis; 2015 Jun; 35():56-61. PubMed ID: 25917963 [TBL] [Abstract][Full Text] [Related]
34. Bactericidal activity of ertapenem against major intra-abdominal pathogens. Borbone S; Cascone C; Santagati M; Mezzatesta ML; Stefani S Int J Antimicrob Agents; 2006 Nov; 28(5):396-401. PubMed ID: 17045463 [TBL] [Abstract][Full Text] [Related]
35. Multicenter in vitro comparison of piperacillin and nine other antibacterials against 1,629 clinical isolates. Greenberg RN; Bowne DB; Gelfand M; Sathe SS Clin Ther; 1990; 12(1):61-70. PubMed ID: 2183941 [TBL] [Abstract][Full Text] [Related]
36. Isolation of Pseudomonas aeruginosa and other bacterial species from ornamental aquarium plants. Trust TJ; Bartlett KH Appl Environ Microbiol; 1976 Jun; 31(6):992-4. PubMed ID: 180888 [TBL] [Abstract][Full Text] [Related]
37. [Bacteria isolated from surgical infections and their susceptibilities to antimicrobial agents. Special references to bacteria isolated between April 1997 and March 1998]. Mashita K; Shinagawa N; Sato T; Hirata K; Katsuramaki T; Mukaiya M; Yura J; Ishibiki K; Ushijima Y; Manabe T; Takeyama H; Hasegawa M; Aikawa N; Yamazaki M; Ishikawa S; Iwai S; Kato K; Mizuno A; Kinoshita H; Morimoto K; Konaga E; Takeuchi H; Fujimoto M; Matsuura Y; Takesue Y; Tanimura H; Ohnishi H; Maeda T; Yokoyama T; Hiyama E; Tanaka N; Inoue F; Iwagaki H; Ikeda S; Yasunami Y; Fuchimoto S; Matsumoto Y; Suzuki Y; Tanaka S; Kimura H Jpn J Antibiot; 2000 Aug; 53(8):533-65. PubMed ID: 11070817 [TBL] [Abstract][Full Text] [Related]
38. Molecular β-lactamase characterization of Gram-negative pathogens recovered from patients enrolled in the ceftazidime-avibactam phase 3 trials (RECAPTURE 1 and 2) for complicated urinary tract infections: Efficacies analysed against susceptible and resistant subsets. Mendes RE; Castanheira M; Woosley LN; Stone GG; Bradford PA; Flamm RK Int J Antimicrob Agents; 2018 Aug; 52(2):287-292. PubMed ID: 29654893 [TBL] [Abstract][Full Text] [Related]
39. Positive Foley catheter tip cultures--fact or fancy? Gross PA; Harkavy LM; Barden GE; Kerstein M JAMA; 1974 Apr; 228(1):72-3. PubMed ID: 4206468 [No Abstract] [Full Text] [Related]
40. [Yearly changes in antibacterial activities of cefozopran against various clinical isolates between 1996 and 2000--II. Gram-negative bacteria]. Suzuki Y; Nishinari C; Endo H; Tamura C; Jinbo K; Hiramatsu N; Akiyama K; Koyama T Jpn J Antibiot; 2002 Apr; 55(2):154-80. PubMed ID: 12071094 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]